Last reviewed · How we verify

NCT05211349

Comparison of Dual-Task Timed Up and Go Test (Cognitive) and 3-m Backwards Walk Test

Status unknown Last updated 27 January 2022
What this trial tests

trial testing Dual-Task Timed Up and Go Test (cognitive) in Stroke in 45 participants. Status unknown.

Timeline
2 January 2022
Primary endpoint
2 January 2023
2 January 2024

Quick facts

Lead sponsorAfyonkarahisar Health Sciences University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment45
Start date2 January 2022
Primary completion2 January 2023
Estimated completion2 January 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Afyonkarahisar Health Sciences University

Who can join

Adults 50 to 85, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Two balance assessment tools that have been used recently have attracted considerable attention: the Dual-Task Timed Up and Go Test (cognitive) (DTUG) and the 3-m Backward Walk Test (3MBWT). The aim of this study is to compare the psychometric properties of two clinically proven balance assessment tools.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparison of psychometric properties of the dual-task timed up-and-go test (cognitive) and the 3-m walk backward test in community-dwelling stroke patients.
    Taşvuran Horata E, Eken F, Taşkın G, Kara G, et al · · 2025 · cited 2× · PMID 39003753 · DOI 10.1080/10749357.2024.2377514

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Afyonkarahisar Health Sciences University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05211349.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing